Carmichael Hill & Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.8K | Sell |
432
-332
| -43% | -$8.3K | ﹤0.01% | 475 |
|
|
2024
Q2 | $14.3K | Buy |
764
+232
| +44% | +$4.33K | 0.01% | 440 |
|
|
2024
Q1 | $10.5K | Sell |
532
-248
| -32% | -$4.89K | ﹤0.01% | 475 |
|
|
2023
Q4 | $13.7K | Hold |
780
| – | – | 0.01% | 442 |
|
|
2023
Q3 | $13.5K | Buy |
780
+176
| +29% | +$3.06K | 0.01% | 428 |
|
|
2023
Q2 | $8.51K | Buy |
604
+152
| +34% | +$2.14K | ﹤0.01% | 489 |
|
|
2023
Q1 | $4.86K | Buy |
452
+180
| +66% | +$1.94K | ﹤0.01% | 546 |
|
|
2022
Q4 | $4.08K | Hold |
272
| – | – | ﹤0.01% | 530 |
|
|
2022
Q3 | $3K | Buy |
272
+24
| +10% | +$265 | ﹤0.01% | 605 |
|
|
2022
Q2 | $2K | Hold |
248
| – | – | ﹤0.01% | 613 |
|
|
2022
Q1 | $2K | Buy |
+248
| New | +$2K | ﹤0.01% | 633 |
|